Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Nov 18 2021
Business
Nov 18 2021
3 min read

Press Release Nov 18 2021

Cadila Healthcare Limited has informed the Exchange regarding a press release dated November 18, 2021, titled "Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA".

View Attachment